SCHEMBL24309592

SCHEMBL24309592

CC(=O)Nc1cccc([S+]([O-])Nc2nc(Oc3ccccc3)cc(-c3ccccc3C)n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NR2E3 Q9Y5X4 1/20 0.36
▸ NUDT1 P36639 1/20 0.36
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ GPR39 O43194 1/20 0.35
▸ BRD4 O60885 2/20 0.35
▸ AURKA O14965 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ TPX2 Q9ULW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309588 0.80 PKM (0.49) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL29566945 0.80 PKM (0.49) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL24309476 0.73 GPR39 (0.41) NPC1RAB9ASMN1; SMN2HTTMAPK1
SCHEMBL24309988 0.72 GPR39 (0.43) NPC1RAB9ASMN1; SMN2LMNAHTT
SCHEMBL26807087 0.72 PKM (0.50) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL24330507 0.71 FFAR1 (0.33) LMNAALDH1A1MAPT
SCHEMBL26807176 0.71 PLA2G7 (0.46) SMN1; SMN2LMNAHTTGAAMAPK1
SCHEMBL26810957 0.68 TSHR (0.54) SMN1; SMN2LMNAHTTALDH1A1GAA
SCHEMBL24310543 0.68 MAP4K1 (0.39) BRD4AURKA
SCHEMBL24310294 0.67 GPR39 (0.38) LMNAHTTALDH1A1GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback